EGFR and ovarian carcinoma: In epithelial ovarian cancer, ZKSCAN3 has shown a more complex oncogenic logic by forming a synergistic regulatory network with epidermal growth factor receptor (EGFR), which is a member of the receptor tyrosine kinase superfamily I [6].